COVID-19 Weekly Briefing for Monday, January 31, 2022
gregoryberkoff.substack.com
January 31, 2022, COVID-19 Weekly Briefing in summary: A discussion of endemicity; new information about long-covid (LC) including clues for assessing LC risk continues to point toward inflammatory autoimmunity and asthma emerges as a risk factor; vaccinated people spread C19 less (including Omicron); Pfizer is testing a new Omicron-specific vaccine; vitamin D supplementation at 1k/day is a good idea but probably won't make a big difference; a new faster spreading Omicron sub-variant called BA-2 is here; Japan fared well by masking and employing the 'Three C's"–countries that act with unity fare better than those that are divided in their pandemic approach.
COVID-19 Weekly Briefing for Monday, January 31, 2022
COVID-19 Weekly Briefing for Monday, January…
COVID-19 Weekly Briefing for Monday, January 31, 2022
January 31, 2022, COVID-19 Weekly Briefing in summary: A discussion of endemicity; new information about long-covid (LC) including clues for assessing LC risk continues to point toward inflammatory autoimmunity and asthma emerges as a risk factor; vaccinated people spread C19 less (including Omicron); Pfizer is testing a new Omicron-specific vaccine; vitamin D supplementation at 1k/day is a good idea but probably won't make a big difference; a new faster spreading Omicron sub-variant called BA-2 is here; Japan fared well by masking and employing the 'Three C's"–countries that act with unity fare better than those that are divided in their pandemic approach.